|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G16H 20/17 | (2018.01) |
| A61M 5/00 | (2006.01) | ||
| A61M 5/14 | (2006.01) | ||
| A61M 5/142 | (2006.01) |
| (11) | Number of the document | 3164170 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15815601.8 |
| Date of filing the European patent application | 2015-07-01 | |
| (97) | Date of publication of the European application | 2017-05-10 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/038843 |
| Date | 2015-07-01 |
| (87) | Number | WO 2016/004210 |
| Date | 2016-01-07 |
| (30) | Number | Date | Country code |
| 201414320863 | 2014-07-01 | US |
| (72) |
ESTES, Mark C. , US
|
| (73) |
Bigfoot Biomedical, Inc. ,
1820 McCarthy Blvd, Milpitas, CA 95035,
US
|
| (54) | GLUCAGON ADMINISTRATION SYSTEM AND METHODS |
| GLUCAGON ADMINISTRATION SYSTEM AND METHODS |